Cargando…

Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli

BACKGROUND: Difficult to express peptides are usually produced by co-expression with fusion partners. In this case, a significant mass part of the recombinant product falls on the subsequently removed fusion partner. On the other hand, multimerization of peptides is known to improve its proteolytic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollaev, Murad, Zabolotskii, Artur, Gorokhovets, Neonila, Nikolskaya, Elena, Sokol, Maria, Tsedilin, Andrey, Mollaeva, Mariia, Chirkina, Margarita, Kuvaev, Timofey, Pshenichnikova, Anna, Yabbarov, Nikita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517049/
https://www.ncbi.nlm.nih.gov/pubmed/34648110
http://dx.doi.org/10.1186/s43141-021-00265-5
_version_ 1784583927115022336
author Mollaev, Murad
Zabolotskii, Artur
Gorokhovets, Neonila
Nikolskaya, Elena
Sokol, Maria
Tsedilin, Andrey
Mollaeva, Mariia
Chirkina, Margarita
Kuvaev, Timofey
Pshenichnikova, Anna
Yabbarov, Nikita
author_facet Mollaev, Murad
Zabolotskii, Artur
Gorokhovets, Neonila
Nikolskaya, Elena
Sokol, Maria
Tsedilin, Andrey
Mollaeva, Mariia
Chirkina, Margarita
Kuvaev, Timofey
Pshenichnikova, Anna
Yabbarov, Nikita
author_sort Mollaev, Murad
collection PubMed
description BACKGROUND: Difficult to express peptides are usually produced by co-expression with fusion partners. In this case, a significant mass part of the recombinant product falls on the subsequently removed fusion partner. On the other hand, multimerization of peptides is known to improve its proteolytic stability in E. coli due to the inclusion of body formation, which is sequence specific. Thereby, the peptide itself may serve as a fusion partner and one may produce more than one mole of the desired product per mole of fusion protein. This paper proposes a method for multimeric production of a human alpha-fetoprotein fragment with optimized multimer design and processing. This fragment may further find its application in the cytotoxic drug delivery field or as an inhibitor of endogenous alpha-fetoprotein. RESULTS: Multimerization of the extended alpha-fetoprotein receptor-binding peptide improved its stability in E. coli, and pentamer was found to be the largest stable with the highest expression level. As high as 10 aspartate-proline bonds used to separate peptide repeats were easily hydrolyzed in optimized formic acid-based conditions with 100% multimer conversion. The major product was represented by unaltered functional alpha-fetoprotein fragment while most side-products were its formyl-Pro, formyl-Tyr, and formyl-Lys derivatives. Single-step semi-preparative RP-HPLC was enough to separate unaltered peptide from the hydrolysis mixture. CONCLUSIONS: A recombinant peptide derived from human alpha-fetoprotein can be produced via multimerization with subsequent formic acid hydrolysis and RP-HPLC purification. The reported procedure is characterized by the lower reagent cost in comparison with enzymatic hydrolysis of peptide fusions and solid-phase synthesis. This method may be adopted for different peptide expression, especially with low amino and hydroxy side chain content. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-021-00265-5.
format Online
Article
Text
id pubmed-8517049
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85170492021-10-27 Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli Mollaev, Murad Zabolotskii, Artur Gorokhovets, Neonila Nikolskaya, Elena Sokol, Maria Tsedilin, Andrey Mollaeva, Mariia Chirkina, Margarita Kuvaev, Timofey Pshenichnikova, Anna Yabbarov, Nikita J Genet Eng Biotechnol Research BACKGROUND: Difficult to express peptides are usually produced by co-expression with fusion partners. In this case, a significant mass part of the recombinant product falls on the subsequently removed fusion partner. On the other hand, multimerization of peptides is known to improve its proteolytic stability in E. coli due to the inclusion of body formation, which is sequence specific. Thereby, the peptide itself may serve as a fusion partner and one may produce more than one mole of the desired product per mole of fusion protein. This paper proposes a method for multimeric production of a human alpha-fetoprotein fragment with optimized multimer design and processing. This fragment may further find its application in the cytotoxic drug delivery field or as an inhibitor of endogenous alpha-fetoprotein. RESULTS: Multimerization of the extended alpha-fetoprotein receptor-binding peptide improved its stability in E. coli, and pentamer was found to be the largest stable with the highest expression level. As high as 10 aspartate-proline bonds used to separate peptide repeats were easily hydrolyzed in optimized formic acid-based conditions with 100% multimer conversion. The major product was represented by unaltered functional alpha-fetoprotein fragment while most side-products were its formyl-Pro, formyl-Tyr, and formyl-Lys derivatives. Single-step semi-preparative RP-HPLC was enough to separate unaltered peptide from the hydrolysis mixture. CONCLUSIONS: A recombinant peptide derived from human alpha-fetoprotein can be produced via multimerization with subsequent formic acid hydrolysis and RP-HPLC purification. The reported procedure is characterized by the lower reagent cost in comparison with enzymatic hydrolysis of peptide fusions and solid-phase synthesis. This method may be adopted for different peptide expression, especially with low amino and hydroxy side chain content. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-021-00265-5. Springer Berlin Heidelberg 2021-10-14 /pmc/articles/PMC8517049/ /pubmed/34648110 http://dx.doi.org/10.1186/s43141-021-00265-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Mollaev, Murad
Zabolotskii, Artur
Gorokhovets, Neonila
Nikolskaya, Elena
Sokol, Maria
Tsedilin, Andrey
Mollaeva, Mariia
Chirkina, Margarita
Kuvaev, Timofey
Pshenichnikova, Anna
Yabbarov, Nikita
Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli
title Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli
title_full Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli
title_fullStr Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli
title_full_unstemmed Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli
title_short Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli
title_sort expression of acid cleavable asp-pro linked multimeric afp peptide in e. coli
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517049/
https://www.ncbi.nlm.nih.gov/pubmed/34648110
http://dx.doi.org/10.1186/s43141-021-00265-5
work_keys_str_mv AT mollaevmurad expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT zabolotskiiartur expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT gorokhovetsneonila expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT nikolskayaelena expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT sokolmaria expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT tsedilinandrey expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT mollaevamariia expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT chirkinamargarita expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT kuvaevtimofey expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT pshenichnikovaanna expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli
AT yabbarovnikita expressionofacidcleavableaspprolinkedmultimericafppeptideinecoli